Oncology & Cancer

Cancer study overturns current thinking about gene activation

(Medical Xpress)—A new Australian study led by Professor Susan Clark from Sydney's Garvan Institute of Medical Research shows that large regions of the genome – amounting to roughly 2% – are epigenetically activated ...

Oncology & Cancer

Scientists discover gene switch important in cancer

Scientists at Karolinska Institutet in Sweden and the University of Helsinki in Finland have shown that the "switches" that regulate the expression of genes play a major role in the development of cancer. In a study, published ...

Oncology & Cancer

Prostate cancer prognosis hope

Cancer of the prostate – the most common male cancer in the UK – presents in two distinct ways: a low-risk type, which may never cause any symptoms, and a high-risk form that needs treatment to prevent it spreading to ...

Genetics

Epigenetics emerges powerfully as a clinical tool

A study coordinated by Manel Esteller, published in Nature Reviews Genetics, highlights the success of this area of research to predict the behavior and weaknesses of tumors.

Oncology & Cancer

Epigenetic causes of prostate cancer

(Medical Xpress)—In about half of all prostate tumours, there are two genetic areas that are fused with one another. When this is not the case, the exact way cancer cells originate in prostate tumours was not clear until ...

Oncology & Cancer

New target for prostate cancer therapy

(Medical Xpress) -- Researchers at Imperial College London have discovered a molecule that plays an important role in driving prostate cancer growth, and could be a target for new therapies.

page 6 from 7